جستجوی استاد راهنمای دانشگاهی

Adrian Fung is a Clinical Professor at Macquarie University and Clinical Associate Professor at the University of Sydney. He serves as Head of the Vitreoretinal Unit at Westmead Hospital and leads multiple national/international committees including Chair of the RANZCO Clinical Standards Committee. His academic qualifications include MBBS(Hons1), dual Masters in Ophthalmic Science and Clinical Epidemiology, and Fellowships in Vitreoretinal Surgery, Medical Retina, Uveitis, and Ocular Oncology. Education: Uveitis Research Fellowship - Bascom Palmer Eye Institute (USA) Ocular Oncology Fellowship - Wills Eye Hospital (USA) Medical Retina Fellowship - Vitreous Retina Macula Consultants of New York (USA) Vitreoretinal Surgery Fellowship - University of British Columbia (Canada) Ophthalmology Training - Sydney Eye Hospital (RANZCO) Research Focus: Specializes in medical retina, vitreoretinal surgery, and clinical epidemiology with emphasis on age-related macular degeneration (AMD), retinal detachment, and ocular oncology. Leads major clinical trials including Bionic Eye Project and Velodrome Port Delivery System studies. Editor roles include Retinal Cases and Brief Reports and Clinical and Experimental Ophthalmology . Recent Articles Trends: Focus on advancing diagnostic techniques via multimodal imaging, optimizing anti-VEGF therapies, and addressing surgical challenges in complex retinal cases. Recent work examines silicone oil drug interactions and rare tumor presentations in genetic syndromes. Awards: 2019 RANZCO Teacher of Excellence 2020 Macula Society Travel Grant Multiple fellowship awards recognizing research contributions Advisory Roles: Principal Investigator for 15+ clinical trials, APVRS Councillor, and sits on 20+ national/international committees. Active in medical education through Ophthalmology Updates! conference and RANZCO training programs. Labs/Teams: Directs research programs at Westmead Hospital and collaborates with global institutions including Bascom Palmer Eye Institute and New York University Eye Centers.

• Ophthalmology
• Retinal Diseases
• Vitreoretinal Surgery
• +۵ مورد دیگر

Roland Chiu serves as a Lecturer in the Department of Mathematics and Natural Sciences at University College Groningen, University of Groningen. Holding a PhD, he maintains an active dual research focus spanning molecular oncology and educational innovation within undergraduate interdisciplinary programs. His research expertise centers on molecular mechanisms in cancer progression and treatment, specifically DNA damage responses, stem cell radiation sensitivity, and targeted pathway interventions in malignancies like glioma and esophageal cancer. He actively contributes to UN Sustainable Development Goals through health-related research and educational initiatives that bridge scientific disciplines. Recent publication trends reveal a strategic expansion into educational scholarship alongside oncology research, highlighted by his 2024 co-edited book on student-directed interdisciplinary projects and multiple clinical radiation studies. This dual trajectory demonstrates integration of rigorous biomedical investigation with pedagogical innovation. His scientific recognition includes: Three consecutive Enhancing Undergraduate Research Grants (2021-2023) Fellowship for Innovation in Teaching (2019) Chiu directs undergraduate research mentorship through grant-funded initiatives, fostering student-led interdisciplinary projects while maintaining clinical research collaborations across Groningen's medical and natural science faculties. His educational work emphasizes co-creation of knowledge between students and faculty. Although specific laboratory infrastructure isn't detailed, his research involves cross-departmental teams including the University Medical Center Groningen, particularly in radiation oncology clinical trials and molecular cancer studies.

• Molecular Biology
• Cancer Research
• Radiation Oncology
• +۳ مورد دیگر

Martin Skovmos Nielsen is an Associate Professor at Aalborg University Hospital's Department of Oncology, part of the Faculty of Medicine at Aalborg University. He holds a PhD in Clinical Medicine (2016) and an MSc in Physics (2002). He has been a Medical Physicist at Aalborg University Hospital since April 2003. His research focuses on radiation therapy techniques, particularly proton therapy for head and neck cancer, radiation-induced toxicity, and clinical trial design. He has led or contributed to multiple projects, including the DAHANCA 35 trial comparing proton and photon therapies. His work emphasizes improving radiation treatment protocols, patient selection models, and dosimetric accuracy. Education: PhD in Clinical Medicine, Aalborg University (2016) MSc in Physics, [Institution Name] (2002) Research Interests: Proton Therapy Applications Radiation Toxicity and Dose Optimization Clinical Trial Methodology in Oncology Head and Neck Cancer Treatment Strategies Key Projects: Feasibility of penumbra electrochemotherapy during pancreatic and hepatic irreversible electroporation (2019–2020) Publications: Over 50 peer-reviewed articles, focusing on radiation therapy advancements, treatment planning, and clinical trial outcomes in oncology.

• Head and Neck Cancer
• Radiation Therapy
• Proton Therapy
• +۴ مورد دیگر

Jan Willem Mens is a Researcher at Erasmus University Rotterdam's Radiotherapy Department, specializing in gynecological oncology with a primary focus on cervical and ovarian cancer treatments. His work integrates advanced radiotherapy techniques and clinical collaboration through the Dutch Gynecological Oncology Audit. His research fingerprint shows dominant expertise in cervical cancer (100%), brachytherapy (62%), gynecological oncology (58%), and uterine cancer (50%), with significant contributions to ovarian cancer (45%) and bladder cancer (33%). Current projects investigate chemoradiotherapy's impact on bone marrow and immune systems, AI-driven brachytherapy planning, photon-counting CT applications, and rehabilitation cost-effectiveness. Recent publications demonstrate a clear trend toward technological innovation in radiation oncology, particularly AI integration for treatment planning and advanced imaging validation. His collaborative approach spans multiple institutions, emphasizing clinical translation and patient-centered outcomes in gynecological malignancies.

• Cervical Cancer
• Brachytherapy
• Gynecological Oncology
• +۴ مورد دیگر

P. Seibold is a researcher at the German Cancer Research Center (DKFZ) specializing in radiation oncology with a focus on prostate cancer treatment and screening. Their work primarily involves studying dose-response relationships in radiotherapy, toxicity prediction, and screening protocols for prostate cancer. Seibold's research interests center on optimizing radiotherapy for prostate cancer patients, with particular emphasis on understanding and predicting treatment-related toxicities. Their work bridges radiation oncology, radiogenomics, and cancer screening methodologies, focusing on improving patient outcomes through precision medicine approaches. Recent publications demonstrate a strong focus on the PROBASE trial, investigating prostate cancer screening strategies for younger men and evaluating optimal diagnostic approaches. Their research on dose-response mapping and polygenic risk scores for radiation toxicity represents cutting-edge work in personalized radiation oncology. Seibold collaborates extensively with urologists, radiation oncologists, and epidemiologists across multiple institutions, contributing to significant advancements in prostate cancer management protocols.

• Radiation Oncology
• Prostate Cancer Research
• Radiotherapy Toxicity
• +۳ مورد دیگر

Dr. Rachel Cross is a Senior Lecturer and Researcher in the Department of Physics at Aberystwyth University, part of the Faculty of Business and Physical Sciences. She holds a PhD in Materials Physics from Wales and completed her BSc in Physics at Aberystwyth University in 2006. Her academic and professional journey includes significant industry experience in nuclear safety and defense engineering before returning to academia for doctoral and research work. Her research is centered on the development and application of instrumentation for the optical characterization of wide band gap materials, with a focus on diamond, nanodiamond bio-interfaces, and bio-pigment photovoltaics. She is known for developing HeLIOS (Hyperspectral Luminescence Imaging for Optical Spectroscopy), a hyperspectral imaging microscope, and has contributed to the European Space Agency’s ExoMars Rover project through calibration and image processing for the PanCam instrument. Her work is highly interdisciplinary, involving collaborations with European research facilities and industry partners. The recent research articles highlight a strong trend in instrumentation development, optical and spectroscopic characterization of advanced materials, and applications in planetary science and astrobiology. Her publications span topics from organic semiconductors and UV luminescence in Mars-analogues to hyperspectral imaging for space missions and biomedical diagnostics. This reflects a career bridging physics, materials science, and space exploration. Research Focus Areas: Optical Spectroscopy & Hyperspectral Imaging Wide Band Gap Semiconductors (e.g., diamond, boron nitride) Bio-material and Nanomaterial Interactions Space Instrumentation (ExoMars PanCam) Image Processing and Radiometric Calibration Scientific Contributions and Collaborations: Rachel Cross has published extensively on topics related to materials characterization and planetary science. Her work has been cited in high-impact journals such as Astrobiology , Icarus , and Faraday Discussions . She collaborates with researchers across Europe and has contributed to major space-related projects. Her research supports several UN Sustainable Development Goals, particularly those related to innovation, clean energy, and sustainable cities. Advising and Research Leadership: While no specific PhD or Master's students are listed, she is actively involved in research supervision and mentoring, as evidenced by her role in collaborative projects and grants. She has supervised doctoral work and contributes to interdisciplinary research teams, including those working on tuberculosis detection and space exploration. Her leadership in instrumentation development underscores her role in guiding technical research directions and training future scientists. Labs and Research Teams: Dr. Cross is affiliated with research groups focused on optical instrumentation and materials physics at Aberystwyth University. She has been involved in projects such as the MINAR (MIne Analog Research) program at Boulby Mine, a deep subsurface analog for planetary exploration. Her work with the PanCam team and collaborations with the European Space Agency highlight her integration into major international research consortia.

• Optical Spectroscopy
• Wide Band Gap Materials
• Hyperspectral Imaging
• +۱۲ مورد دیگر

Shuai Leng, Ph.D., is a Professor of Medical Physics and Consultant in the Division of Medical Physics at Mayo Clinic's Department of Radiology. His research focuses on advancing CT imaging techniques, including photon-counting detectors, multienergy CT, and dynamic (4-D) CT to improve diagnostic accuracy while reducing radiation exposure. He leads efforts in image reconstruction algorithms, radiation dose optimization, and task-based image quality assessment. Education: Ph.D. in Medical Physics, University of Wisconsin, Madison (2008) MS in Engineering Physics, Tsinghua University (2003) BS in Engineering Physics, Tsinghua University (2001) Research Interests: Dr. Leng's work spans CT technology innovation, including photon-counting detectors, dual-energy imaging, radiation dosimetry, and application-driven algorithms for clinical outcomes. He actively explores novel applications like phase-contrast CT and 4-D imaging for osteoarthritis diagnosis. Awards: 2024 Fellow, SPIE and SCCT 2022 Teacher of the Year, Mayo Clinic Multiple RSNA and industry awards for dose reduction and imaging innovation Grants/Advising: Leads NIH-funded projects on joint instability diagnosis via AI-enhanced CT and coronary atherosclerosis imaging. Engaged in over 377 publications and international standards committees (AAPM, IEC). Labs/Teams: Core member of the CT Clinical Innovation Center and collaborates globally on imaging standards and technology translation.

• Medical Physics
• Computed Tomography (CT)
• Image Reconstruction
• +۸ مورد دیگر

Vince Maes is a Research Fellow at KU Leuven's Numerical Analysis and Applied Mathematics (NUMA) research unit, supported by an FWO (Research Foundation - Flanders) special research associate fellowship. His work centers on computational methods for plasma physics and kinetic theory, with office location at Celestijnenlaan 200a, box 2402, room 02.49 in Leuven. Maes' research spans numerical analysis and applied mathematics, specializing in Monte Carlo particle tracing, statistical error prediction, and kinetic-diffusion algorithms. He develops computational frameworks for plasma edge modeling in fusion devices and dose estimation in radiation therapy, bridging theoretical mathematics with practical applications in energy and healthcare. His methodological innovations address challenges in rarefied gas dynamics and high-collisional regimes. Analysis of his 2023-2025 publications reveals consistent focus on Monte Carlo simulation accuracy, hybrid modeling techniques, and open-science practices. Key themes include statistical error quantification in particle tracing, Markov process applications on grids, and moment model development for plasma edge simulations. Collaborations with KU Leuven researchers dominate his output, particularly with Bossuyt, Vandecasteele, Dekeyser, Koellermeier, Baelmans, and Samaey. Funded through a competitive FWO fellowship, Maes contributes significantly to reproducible research by releasing code repositories alongside publications. While no formal advisees are documented, he actively participates in the NUMA research ecosystem through conference presentations (RGD32, NumKin) and collaborative projects. His work demonstrates strong integration of mathematical theory with plasma physics and medical applications. As part of NUMA at KU Leuven, Maes operates within a specialized computational mathematics team focused on scientific computing for plasma physics and radiation therapy. The group maintains active collaborations with plasma physics laboratories and medical physics departments, developing numerical tools for fusion energy research and cancer treatment optimization through kinetic-diffusion algorithms.

• Numerical Analysis
• Applied Mathematics
• Monte Carlo Methods
• +۳ مورد دیگر

Alexandru Nemțoi serves as an Associate Professor at the Faculty of Medicine and Biological Sciences, Stefan cel Mare University of Suceava, specializing in Oral and Maxillofacial Surgery. A dual-certified dentist and physician, he holds a Doctorate in Medical Sciences from the University of Medicine and Pharmacy 'Gr. T. Popa' Iași and maintains active clinical practice in dentistry, maxillofacial surgery, and radiology since 2011. 2010: Dentist (Ministry of Education, Research, Youth and Sports) 2011: Master in Oro-Dental Public Health 2014: Doctor in Medical Sciences, Dentistry 2016: General Practitioner & Oral and Maxillofacial Surgery Specialist 2019: Radiology and Medical Imaging Resident His research centers on advanced imaging applications in maxillofacial contexts, with pioneering work in Cone Beam Computed Tomography (CBCT) for anatomical assessment, surgical planning, and pathological diagnosis. Key focus areas include cleft lip/palate deformities, dental implantology, sinus augmentation, and trauma management, emphasizing population-specific anatomical variations in Northeastern Romania. Analysis of his 15 most recent publications (2013-2019) reveals consistent innovation in CBCT methodology, with 73% dedicated to anatomical studies of maxillofacial structures and 60% addressing cleft-related pathologies. His work bridges radiology, surgery, and dental implantology, establishing standardized protocols for Romanian clinical practice. Dr. Nemțoi actively mentors undergraduate students in anatomy, radiology, and medical assistance while maintaining clinical residencies. He contributes to surgical teams through the European Association of Cranio-Maxillo-Facial Surgery and co-founded Romania's National Association of Dental and Maxillofacial Radiology.

• Oral and Maxillofacial Surgery
• Dento-Maxillo-Facial Radiology
• Cone Beam Computed Tomography
• +۳ مورد دیگر

Navid Zeraatkar, PhD, is a Lecturer at the T.H. Chan School of Medicine within UMass Chan Medical School, specializing in Radiology. His research focuses on advanced imaging technologies and computational methodologies in nuclear medicine. BSc in Electronics Engineering from Ferdowsi University of Mashhad MSc in Medical Radiation Engineering from Shahid Beheshti University PhD in Molecular & Cellular Imaging from Tehran University of Medical Sciences Dr. Zeraatkar's work spans Medical Imaging , Nuclear Medicine , and Biomedical Engineering , with particular emphasis on: Optimization of SPECT/PET systems Image reconstruction algorithms Collimator design and radiation detection Deep learning applications in medical imaging Partial volume correction techniques Small-animal imaging systems His publications (2011-2025) demonstrate expertise in gamma camera technologies, computational modeling, and translational imaging research. Key collaborations include Michael A. King and other experts in biomedical instrumentation. Dr. Zeraatkar contributes to the King Lab at UMass Chan Medical School, working with teams on preclinical and clinical imaging solutions. Current projects focus on adaptive multi-pinhole SPECT systems and AI-driven image enhancement.

• Medical Imaging
• Nuclear Medicine
• Biomedical Engineering
• +۳ مورد دیگر

Prof. Dr. Oliver Jäkel is a leading academic and medical physicist serving as Full Professor for Medical Physics at the Medical Faculty Heidelberg of Heidelberg University, Head of the Division of Medical Physics in Radiation Oncology at the German Cancer Research Center (DKFZ), and Medical Physics Director of the Heidelberg Ion Beam Therapy Center (HIT) at Heidelberg University Hospital (UKHD). He holds an Scopus ID: 7003530041, ORCID: 0000-0002-6056-9747, and an h-index of 57, reflecting his significant scholarly impact. His research interests are centered on medical physics in radiation oncology , particularly in particle therapy involving protons, carbon ions, and helium ions. Key areas include dosimetry , MR-guided and adaptive radiotherapy , treatment planning , in vivo monitoring using secondary fragment tracking , and AI applications in imaging and contouring . He has pioneered work in helium beam radiography, motion management, and Monte Carlo simulations for dose verification. His recent publications (2024–2025) reveal a strong focus on deep learning for MRI-to-CT conversion, intrafractional motion tracking, and quality assurance in hybrid MRI-particle therapy systems. These works span journals such as Physics in Medicine and Biology , Medical Physics , and Cancers , demonstrating a consistent trend toward integrating advanced imaging, AI, and novel particle beams into clinical radiotherapy workflows. Among his scientific honors are: Chair of ICRU Report 93 on Light Ion Beam Therapy reporting Spokesperson for HGF and DFG research groups in hadron therapy Accredited mentor for medical physics experts Member of IAEA and ICRU task groups Chair of DKFZ’s Commission for Good Scientific Practice Prof. Jäkel has supervised one habilitation and 31 dissertations, indicating active academic mentorship. He leads international Master’s programs in medical physics and has organized summer schools in Chile and Thailand. He is involved in multiple advisory boards, including the DFG, FCT Portugal, and Ontario’s Univ. Health Network. His leadership extends to large-scale research initiatives such as the Heidelberg Institute for Radiation Oncology (HIRO) and the development of postgraduate curricula in medical physics. He is actively involved in laboratory and clinical research at DKFZ and HIT, where his team develops and validates novel imaging and dosimetry systems for particle therapy, including Timepix-based detectors, FLUKA simulations, and MR-integrated workflows. Future research directions include expanding helium ion therapy, improving biological effectiveness models, and advancing AI-driven adaptive radiotherapy.

• Medical Physics
• Radiation Oncology
• Ion Beam Therapy
• +۱۵ مورد دیگر

Xi Wu is a faculty member at Chengdu University of Information Technology , affiliated with the School of Computer Science . He holds a PhD from Sichuan University (2012, College of Electronic and Information Engineering). Current Research Focus: Medical imaging, computer vision, and deep learning applications in healthcare Key Themes: PET image reconstruction, radiotherapy dose prediction, GANs, diffusion models, and facial expression recognition His recent work explores transformer architectures , semi-supervised learning , and uncertainty-aware models for tasks like tumor segmentation and multi-organ analysis. Publications emphasize cross-domain adaptation and multi-modal medical imaging .

• Computer Science
• Artificial Intelligence
• Medical Image Analysis
• +۳ مورد دیگر

Isabel Pires is a Lecturer in Cancer Biology at The University of Manchester, UK, and holds a PhD in Pharmacology from The University of Manchester. Her research focuses on hypoxia biology in cancer, including its role in therapy resistance, metastasis, and novel biomarkers. She also investigates interstitial fluid flow (IFF) and microfluidic models like the 'spheroid-on-chip' to study tumor microenvironment interactions. Education: PhD in Pharmacology, The University of Manchester (2003–2007) Licenciatura in Biology, Universidade de Coimbra, Portugal (1997–2002) Research Interests: Her lab explores three main areas: (1) hypoxia as a biomarker for disease outcomes, (2) hypoxia-targeted therapies to enhance radiotherapy efficacy, and (3) the interplay between IFF and hypoxia in tumor progression. Recent work includes developing microfluidic platforms to model tumor biology under flow conditions. Grants & Leadership: Team leader of a £340k University of Hull PhD studentship cluster (2019–2023) ARR Trustee and member of the LH Gray Memorial Trust (2022–present) Labs/Teams: Utilizes advanced microfluidic technologies and in vitro 3D models to study tumor microenvironment dynamics and therapeutic responses.

• Hypoxia Biology
• Radiotherapy Resistance
• Cancer Biology
• +۳ مورد دیگر

Michael F. McNitt-Gray is a Professor in Radiological Sciences at the University of California, Los Angeles (UCLA). His research focuses on medical imaging technologies, particularly in computed tomography (CT), radiation dose assessment, and artificial intelligence applications in medical imaging. He holds a PhD in Biomedical Physics from UCLA (1993), an MSEE from Carnegie-Mellon University (1980), and a BSEE from Washington University in St. Louis (1979). Key areas of research include optimizing CT protocols, radiation dose reduction, quantitative imaging biomarkers, and lung disease diagnosis. He has contributed to initiatives like the Lung Image Database Consortium (LIDC) and developed tools for radiomic feature standardization and AI-driven image analysis. His work addresses challenges in lung cancer screening, nodule detection, and emphysema assessment, with a strong emphasis on reproducibility and clinical translation. His awards include Fellowships from the American Association of Physicists in Medicine (2011) and the American College of Radiology (2017). His publications span over three decades, addressing topics such as CT dose estimation, AI in medical imaging, and radiomics. He has collaborated extensively on multi-institutional studies and clinical trials, focusing on improving diagnostic accuracy and safety in medical imaging.

• Medical Imaging
• Radiation Dose Assessment
• Artificial Intelligence in Medical Imaging
• +۳ مورد دیگر

Michael Hughes is an Associate Professor at the Australian National University (ANU) and Head of the ANU Sydney Clinical School. He is a surgical oncologist with over 30 years of experience specializing in melanoma, breast cancer, sarcoma, and soft tissue tumors. He previously served as Head of the Clinical School at the Sydney Adventist Hospital and as Clinical Director of Surgical Services there (2019–2023). He chairs the Breast and Surgical Oncology multidisciplinary teams at Sydney Adventist Hospital and leads Northern Surgical Oncology, a practice with six surgeons. Education: MBBS First Class Honours (University of Sydney, 1989), FRACS General Surgery (Royal Australasian College of Surgeons, 1997). Research focuses on surgical oncology, particularly breast cancer biomarkers, lymphedema management, and re-irradiation techniques. Recent publications address diagnostic concordance in HER-2 receptor testing, subclinical lymphedema surveillance, and case studies challenging radiation therapy protocols. Awards include FRACS General Surgery and MBBS Honours. He has held leadership roles in the Royal Australasian College of Surgeons and Cancer Australia.

• Surgical Oncology
• Breast Cancer
• Melanoma Treatment
• +۳ مورد دیگر